References
[1] 中国医师协会新生儿专业委员会. 早产儿脑损伤诊断与防治 专家共识[J]. 中国当代儿科杂志, 2012, 14(12): 883-884.
[2] Juul SE, Ferriero DM. Pharmacologic neuroprotective strategies in neonatal brain injury[J]. Clin Perinatol, 2014, 41(1): 119-131.
[3] Mazur M, Miller RH, Robinson S. Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury[J]. J Neurosurg Pediatr, 2010, 6(3): 206-221.
[4] Sirén AL, Fasshauer T, Bartels C, et al. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system[J]. Neurotherapeutics, 2009, 6(1): 108-127.
[5] 龙莎莎, 程国强. 早产儿脑白质损伤治疗的循证医学进展[J]. 临床儿科杂志, 2015, 33(3): 287-290.
[6] 王晓琴, 王莹, 李红. 早产儿脑损伤的危险因素[J]. 中国新生 儿科杂志, 2015, 30(4): 286-288.
[7] Hassell KJ, Ezzati M, Alonso-Alconada D, et al. New horizons for newborn brain protection: enhancing endogenous neuroprotection[J]. Arch Dis Child Fetal Neonatal Ed, 2015, 100(6): F541-F552.
[8] 中华医学会儿科学分会新生儿学组, 《中华儿科杂志》编辑 委员会. 早产儿脑室周围-脑室内出血与脑室周围白质软化 的诊断建议[J]. 中华儿科杂志, 2007, 45(1): 34-36.
[9] 马力, 温晓红, 杨海波, 等. 影响早产儿脑损伤的相关因素 分析[J]. 中国当代儿科杂志, 2016, 18(6): 471-475.
[10] 周丛乐. 早产儿脑白质损伤[M]//周丛乐. 新生儿神经病学. 第1 版. 人民卫生出版社, 2012: 376-383.
[11] Panigrahy A, Wisnowski JL, Furtado A, et al. Neuroimaging biomarkers of preterm brain injury: toward developing the preterm connectome[J]. Pediatr Radiol, 2012, 42(Suppl 1): S33-S61.
[12] Jantzie LL, Miller RH, Robinson S. Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury[J]. Pediatr Res, 2013, 74(6): 658-667.
[13] 张冬梅, 王来栓. 早产儿脑病研究进展[J]. 国际儿科学杂志, 2012, 39(2): 173-176.
[14] Marret S, Marchand-Martin L, Picaud JC, et al. Brain injury in very preterm children and neurosensory and cognitive disabilities during childhood: the EPIPAGE cohort study[J]. PLoS One, 2013, 8(5): e62683.
[15] Wu YW, Gonzalez FF. Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy?[J]. Dev Med Child Neurol, 2015, 57(Suppl 3): 34-39.
[16] Traudt CM, Juul SE. Erythropoietin as a neuroprotectant for neonatal brain injury: animal models[J]. Methods Mol Biol, 2013, 982: 113-126.
[17] Leuchter RH, Gui L, Poncet A, et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age[J]. JAMA, 2014, 312(8): 817-824.
[18] Ma W, Kantarjian H, Zhang K, et al. Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome[J]. BMC Med Genet, 2010, 11: 163.
[19] Douglas-Escobar M, Weiss MD. Biomarkers of brain injury in the premature infant[J]. Front Neurol, 2013, 3: 185.
[20] Hergenroeder GW, Redell JB, Moore AN, et al. Biomarkers in the clinical diagnosis and management of traumatic brain injury[J]. Mol Diagn Ther, 2008, 12(6): 345-358.
[21] Rees S, Hale N, De Matteo R, et al. Erythropoietin is neuroprotective in a preterm ovine model of endotoxin-induced brain injury[J]. J Neuropathol Exp Neurol, 2010, 69(3): 306-319.
[22] Lemus-Varela ML, Flores-Soto ME, Cervantes-Munguía R, et al. Expression of HIF-1 alpha, VEGF and EPO in peripheral blood from patients with two cardiac abnormalities associated with hypoxia[J]. Clin Biochem, 2010, 43: 234-239.
[23] Alexander ML, Hill CA, Rosenkrantz TS, et al. Evaluation of the therapeutic benefit of delayed administration of erythropoietin following early hypoxic-ischemic injury in rodents[J]. Dev Neurosci, 2012, 34(6): 515-524.
[24] Yu Z, Tang L, Chen L, et al. Erythropoietin reduces brain injury after intracerebral hemorrhagic stroke in rats[J]. Mol Med Rep, 2013, 8(5): 1315-1322.
[25] Barton SK, Tolcos M, Miller SL, et al. Ventilation-Induced Brain Injury in Preterm Neonates: A Review of Potential Therapies[J]. Neonatology, 2016, 110(2): 155-162.